Dr. Forrest was founding CFO and COO and is a co-founder of Cidara Therapeutics as well as co-inventor of the company’s Cloudbreak™ anti-infective immunotherapy platform. From 2005 to 2014, Dr. Forrest held positions of increasing responsibility at 5AM Ventures, an early stage life science venture capital firm. While at 5AM, Dr. Forrest led or supported investments in Relypsa, Flexion Therapeutics, Semprus Biosciences (acquired by Teleflex) and Marcadia Biotechnologies (acquired by Roche), among others. Dr. Forrest has served as a review member of the Princeton University IP Accelerator Fund, and leads organization of the rEvolution Symposium, a leading meeting for heads of life science R&D. Dr. Forrest holds a B.S. in biology from Boston College and Ph.D. in molecular biology from Princeton University.